Company / Capital Expenditures
Beta Bionics, Inc. Capital Expenditures History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$5.3M
FY2025
5-year range
$402.0K / $5.3M
FY2023-FY2025
Trend
+56.0%
vs FY2024
Sector context
#129 of 151
Health Care
What the data says
Beta Bionics, Inc.'s capital expenditures of $5M is lower than 85% of companies in the Health Care sector (FY2025). Improved from $402,000 to $5M over the past 2 years.
Based on SEC 10-K filings.
$5M in FY2025.
Improved from $402,000 to $5M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 151This company $5.3M Sector average $271.7M
▼
-98.1% below sector average
Key checks
Key Insights
- In FY2025, capital expenditures increased 56.0% year-over-year.
- Ranks #129 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.3M | +56.0% |
| FY2024 | $3.4M | +744.5% |
| FY2023 | $402.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026